VPC
Vestal Point Capital Portfolio holdings
AUM
$2.73B
1-Year Est. Return
128.57%
This Fund
S&P 500
1 Year Est. Return
+128.57%
AUM
$2.73B
AUM Growth
+$522M
(+24%)
Holding
105
Top Buys
| 1 | +$134M | |
| 2 | +$118M | |
| 3 | +$104M | |
| 4 |
ABVX
Abivax
ABVX
|
+$98.2M |
| 5 |
Merck
MRK
|
+$72.7M |
Top Sells
| 1 | +$104M | |
| 2 | +$87.8M | |
| 3 | +$76.8M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$70.3M |
| 5 |
Becton Dickinson
BDX
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cytokinetics
CYTK
$7.4B
| – | – |
-725,000
|
|
||
102
Danaher
DHR
$132B
| – | – |
-150,000
|
|
||
103
Dianthus Therapeutics
DNTH
$3.37B
| – | – |
-1,180,000
|
|
||
104
Establishment Labs
ESTA
$1.86B
| – | – |
-100,000
|
|
||
105
Exact Sciences
EXAS
$19.8B
| – | – |
-75,000
|
|